Abstract
The present Research Project is formulated in two parts, Part I and Part II, associated with two cohorts of patients with primary immunedeficiencies (PIDs): autoimmune lymphoproliferative syndrome (ALPS) with undefined genetic etiology (ALPS-U) and agammaglobulinemia linked to X (XLA), respectively. Although different, such pathologies present some clinical manifestations in common charac…